Literature DB >> 1108645

Drug default among schizophrenic patients.

A A Nelson, B H Gold, R A Hutchinson, E Benezra.   

Abstract

This study attempted to isolate the relationship of two variables that operate to influence drug compliance among schizophrenic patients: the patient's attitude toward his disturbance, and the treatment milieu employed during hospitalization. Schizophrenic patients were administered the Rorschach test upon admission to the psychiatric service of a general hospital to determine their perception of their disturbance. Results of this psychological test were used to randomly select 48 patients who were then randomly assigned to two treatment milius: self-medication during hospitalization and as an outpatient, and traditional drug administration during hospitalization and self-medication as an outpatient. Phenothiazine drugs were used, and compliance was determined by urinalysis. Patients who were generally realistic in their perception of their disorder were significantly more compliant during hospitalization and subsequent outpatient treatment. The treatment milieu variable was not a significant influence. Further analysis via a linear regression model confirmed the relationship of several other compliance factors previously reported in the literature. The role of the patient's attitude toward his illness and the importance of personal relationships are considered in terms of the role of the pharmacist in influencing compliance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1108645

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  9 in total

1.  Treatment compliance and hostility levels of head-injured psychiatric outpatients.

Authors:  I M Salloum; E J Jenkins; B Thompson; D Levi; Y Burnett
Journal:  J Natl Med Assoc       Date:  1990-08       Impact factor: 1.798

2.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Authors:  Martijn J Kikkert; Aart H Schene; Maarten W J Koeter; Debbie Robson; Anja Born; Hedda Helm; Michela Nose; Claudia Goss; Graham Thornicroft; Richard J Gray
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

3.  Drug compliance and the psychiatric patient.

Authors:  A Seltzer; B F Hoffman
Journal:  Can Fam Physician       Date:  1980-05       Impact factor: 3.275

Review 4.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

Review 5.  The problem of non-compliance with drug therapy.

Authors:  L Evans; M Spelman
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

Review 6.  Thioridazine for schizophrenia.

Authors:  M Fenton; J Rathbone; J Reilly; A Sultana
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

7.  Association between Therapeutic Alliance and Adherence in Outpatient Schizophrenia Patients.

Authors:  Jhin Goo Chang; Daeyoung Roh; Chan-Hyung Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-05-31       Impact factor: 2.582

8.  Psychoeducational intervention and prevention of relapse among schizophrenic disorders in the Italian community psychiatric network.

Authors:  Eugenio Aguglia; Elisabetta Pascolo-Fabrici; Francesca Bertossi; Mariano Bassi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2007-06-25

9.  A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss.

Authors:  Maarten Treur; Bart Heeg; Hans-Jürgen Möller; Annette Schmeding; Ben van Hout
Journal:  BMC Health Serv Res       Date:  2009-02-18       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.